Please login to the form below

Not currently logged in
Email:
Password:

Ajovy

This page shows the latest Ajovy news and features for those working in and with pharma, biotech and healthcare.

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Lundbeck bolts on migraine drug via $1.95bn deal to buy Alder

Alder’s drug is given every three months, whereas Amgen’s  Aimovig(erenumab) and Lilly’s  Emgality(galcanezumab) are taken once a month and Teva’s  Ajovy(fremanezumab) is dosed either ... First-to-market Aimovig brought in $83m in sales the

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics